(Q39480187)

12 September 2017

1 reference

title

Thromboembolism and antithrombotic therapy in peripheral arterial disease (English)

1 reference

12 September 2017

1 reference

H Bounameaux

1

1 reference

12 September 2017

R Verhaeghe

series ordinal

2

1 reference

12 September 2017

M Verstraete

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 December 1986

1 reference

Journal of the American College of Cardiology

12 September 2017

1 reference

12 September 2017

8

1 reference

12 September 2017

6 Suppl B

1 reference

12 September 2017

98B-103B

1 reference

Role of platelet activation and fibrin formation in thrombogenesis

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Does 111indium-platelet deposition predict patency in prosthetic arterial grafts?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Outcome of Recent Thromboembolic Occlusions of Limb Arteries Treated with Streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Human tissue-type plasminogen activator: from the laboratory to the bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Selective Clot Lysis with Low-Dose Streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Local low-dose thrombolytic therapy of peripheral arterial occlusions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Chronic upper extremity arterial insufficiency. Etiology, manifestations, and operative management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Treatment and sequelae of angiographic complications in children

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Effect of daily muscular exercise in patients with intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Drug therapy: vasodilator drugs in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Current Therapy for Intermittent Claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Buflomedil in arterial occlusive disease: results of a controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Placebo-controlled, double-blind, two-centre trial of ketanserin in intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

The Natural History of Bilateral Aortofemoral Bypass Grafts for Ischemia of the Lower Extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Aortofemoral graft for multilevel occlusive disease. Predictors of success and need for distal bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Effect of arterial reconstruction on limb salvage: a ten-year appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

TRANSLUMINAL TREATMENT OF ARTERIOSCLEROTIC OBSTRUCTION. DESCRIPTION OF A NEW TECHNIC AND A PRELIMINARY REPORT OF ITS APPLICATION

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

[Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique) (author's transl)]

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Transluminal Angioplasty of the Iliac, Femoral, and Popliteal Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Percutaneous Transluminal Angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

The effect of streptokinase infusion on chronic arterial occlusions and stenoses

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Clinical trial of Brinase and anticoagulants as a method of treatment for advanced limb ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Intra-arterial hyaluronidase in severe peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Intra-arterial infusion of prostaglandin E1 in normal subjects and patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Successful therapy of advanced arteriosclerosis obliterans with prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

EPOPROSTENOL (PROSTACYCLIN) AND SEVERE ARTERIAL DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

Conservative treatment of gangrene using mineralocorticoid-induced moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980011-0

7 January 2021

10.1016/S0735-1097(86)80011-0

Identifiers

DOI

1 reference

12 September 2017

1 reference